- Home
- WST vs LII Comparison
WST vs LII Comparison
Compare WST & LII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WST
- LII
- Stock Information
- Founded
- WST 1923
- LII 1895
- Country
- WST United States
- LII United States
- Employees
- WST N/A
- LII 14200
- Industry
- WST Medical/Dental Instruments
- LII Industrial Machinery/Components
- Sector
- WST Health Care
- LII Industrials
- Exchange
- WST Nasdaq
- LII Nasdaq
- Market Cap
- WST 20.1B
- LII 17.4B
- IPO Year
- WST N/A
- LII 1999
- Fundamental
- Price
- WST $300.88
- LII $497.12
- Analyst Decision
- WST Strong Buy
- LII Hold
- Analyst Count
- WST 8
- LII 11
- Target Price
- WST $348.00
- LII $611.55
- AVG Volume (30 Days)
- WST 707.3K
- LII 536.0K
- Earning Date
- WST 10-23-2025
- LII 10-22-2025
- Dividend Yield
- WST 0.30%
- LII 1.97%
- EPS Growth
- WST 0.17
- LII 12.46
- EPS
- WST 6.75
- LII 23.67
- Revenue
- WST $3,017,900,000.00
- LII $5,345,300,000.00
- Revenue This Year
- WST $6.49
- LII $1.59
- Revenue Next Year
- WST $6.23
- LII $6.86
- P/E Ratio
- WST $44.06
- LII $20.97
- Revenue Growth
- WST 4.92
- LII 3.77
- 52 Week Low
- WST $187.43
- LII $485.47
- 52 Week High
- WST $352.33
- LII $689.44
- Technical
- Relative Strength Index (RSI)
- WST 73.38
- LII 37.29
- Support Level
- WST $297.20
- LII $485.47
- Resistance Level
- WST $322.34
- LII $568.98
- Average True Range (ATR)
- WST 7.14
- LII 18.70
- MACD
- WST 3.47
- LII -3.02
- Stochastic Oscillator
- WST 66.90
- LII 13.94
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
About LII Lennox International Inc.
Lennox International manufactures and distributes heating, ventilating, air conditioning, and refrigeration products to replacement (75% of sales) and new construction (25% of sales) markets. In fiscal 2024, residential HVAC was 67% of sales and commercial HVAC and Heatcraft refrigeration was 33% of sales. The company goes to market with multiple brands, but Lennox is the company's flagship HVAC brand. The Texas-based company is focused on North America after the sale of its European HVAC and refrigeration businesses in late 2023.